CUTERA INC
cutera.comNo Longer Reporting
The company has not filed an annual or quarterly report since its Q3 FY2024 10-Q, filed Nov 12, 2024. Its latest SEC filing is a 25-NSE from Jul 16, 2025.
10-Q for Q3 FY2024, filed Nov 12, 2024
The sections below describe the company as of the FY2023 annual report.
What Did They Do?
Sells energy-based aesthetic systems and related products for medical practitioners, who use them to treat skin conditions, acne, body contouring, hair removal and other aesthetic concerns.
10-K for FY2023, filed May 10, 2024Cutera was formed in 1998 as a Delaware corporation and is a global provider of aesthetic and dermatology solutions for medical…View ↗
Cutera, Inc. (“Cutera” or the “Company”) develops, manufactures, distributes, and markets energy-based product platforms for medical…View ↗
The Company currently markets the following key platforms: AviClear, enlighten, excel, truSculpt, Secret PRO, Secret RF, and xeo — each of…View ↗
How Did They Make Money?
Medical practitioners and distributors pay for systems and upgrades when shipped or received. The company also sells replacement consumables and skincare products when shipped, and earns service-contract fees over their terms, with treatment fees charged when treatment begins.
10-K for FY2023, filed May 10, 2024For the Company’s system sale arrangements that include an extended service contract, the period of service commences at the expiration of…View ↗
For systems sold directly to end-customers that are credit approved, revenue is recognized when the Company transfers control to the…View ↗
The Company leases certain AviClear devices to customers and receives a fixed annual license fee over the term of the arrangement and…View ↗
The Company classifies its customers' purchases of replacement cycles for truSculpt and truFlex, as well as replacement hand pieces, xeo…View ↗
The Company sold third-party manufactured skincare products in Japan. The skincare products were purchased from a third-party manufacturer…View ↗
The Company offers post-warranty services to its customers through extended service contracts that cover parts and labor for a term of one…View ↗
$212.4M
-
10-K for FY2023, filed May 11, 2024
$212.4M ↗
| Segment | Share | Revenue | How money arrives |
|---|---|---|---|
|
Systems
|
61%
FY2020: 61%
|
Systems, FY2023
$130.5M Sources
|
|
|
Consumables
Sold outright
10-K for FY2023, filed May 10, 2024 |
12%
FY2020: 6.3%
|
Consumables, FY2023
$25.3M Sources
|
Sold outright |
|
Skincare
Sold outright
10-K for FY2023, filed May 10, 2024 |
16%
FY2020: 17%
|
Skincare, FY2023
$34M Sources
|
Sold outright |
|
Service
|
11%
FY2020: 15%
|
Service, FY2023
$22.6M Sources
|
Who Were Their Customers?
Medical practitioners, including dermatologists, plastic surgeons and other aesthetic providers, buy directly in the company's direct-sales markets; elsewhere, distributors sell its products. Practitioners can also order refills and consumable tips through the company website.
10-K for FY2023, filed May 10, 2024The Company markets, sells, and services the Company’s products through direct sales and service employees in North America, Australia, New…View ↗
The Company also sells certain items like hand piece refills, cycle refills, consumable tips, and marketing brochures through the Company’s…View ↗
Customers generally demand quality, performance, ease of use and high productivity in relation to the cost of ownership. The Company…View ↗
The Company seeks to establish strong ongoing relationships with its customers through the ability to upgrade select products, sales of…View ↗
How Were They Changing?
- Net income
-
Sources
10-Q for Q3 FY2024, filed Nov 13, 2024
−$39MView ↗
- ▼ −12% (Loss)
- vs −$44.3M in Q3 FY2023
10-Q for Q3 FY2024, filed Nov 12, 2024
Open tableView ↗
-
Mar 10, 2025
Cutera announced plans to delist its common stock from Nasdaq.
The company said it intends to delist and has not arranged another exchange listing or quotation.
Sources
8-K, filed Mar 10, 2025
On March 10, 2025, the Company delivered formal notice to Nasdaq that the Company intends to voluntarily delist its common stock, par value…View ↗
-
Mar 5, 2025
Cutera filed for Chapter 11 bankruptcy protection.
The company continues operating as a debtor in possession while pursuing a restructuring with senior noteholders.
Sources
8-K, filed Mar 5, 2025
On March 5, 2025 (the “Petition Date”), Cutera, Inc., a Delaware corporation (“Cutera”) and Crystal Sub, LLC, a Texas limited liability…View ↗
Grew. Revenue grew 17% in 4 years, from $181.7M in FY2019 to $212.4M in FY2023, about 4% a year.
Skincare distribution ended
The older report described skincare distribution in Japan as an ongoing business; the latest report says the distribution agreement ended and the products were transferred to ZO.
10-K for FY2020, filed Mar 23, 2021 10-K for FY2023, filed May 10, 2024In addition to the above mentioned seven primary systems, the Company continues to generate revenue from its legacy products such as…View ↗
AviClear added
The latest report adds AviClear, an acne-treatment device and associated treatment fees, to the product portfolio; it does not appear in the older report's platform list.
10-K for FY2020, filed Mar 23, 2021 10-K for FY2023, filed May 10, 2024Cutera was formed in 1988 as a Delaware corporation and is a global provider of laser and energy-based aesthetic systems for practitioners…View ↗
Who Did They Compete With?
Competes with Abbvie, Bausch Health, InMode, Lutronic, Sisram, Candela, Sciton, BTL Industries, Accure Acne, Cynosure, Lumenis, Cartessa Aesthetics, Reveal Lasers, and Aesthetic Management Partners
10-K for FY2023, filed May 10, 2024The industry in which the Company operates is subject to intense competition. The Company’s products compete against conventional…View ↗
Loading...
